Verified
来源、主体与时间与首次落库记录一致。
| 文章 | STAT+: Cytokinetics details trial win for what could be its next approval |
| 信任等级 | Aggregate |
| 发布主体 | — |
| 来源 | https://www.statnews.com/2026/08/28/cytokinetics-myqorzo-aficamten-nhcm-acacia-trial-success/?utm_campaign=rss |
| 创建时间 | Friday, 28 August 2026 - 18:31 |
| 已记录哈希 | cb4397b858f33ec06a91fd72b94f6aab9c76e08bee3676c6456d01e3215609f6 |
| 重算哈希 | cb4397b858f33ec06a91fd72b94f6aab9c76e08bee3676c6456d01e3215609f6 |
哈希算法：sha256(来源URL|主体ID|创建时间戳)，主体缺失时主体ID为 0。